Citizens Commission on Human RightsNASHVILLE, TENNESSEE   615-784-8120

The Mental Health Watchdog: Investigating & Exposing Human Rights Violations

Victim of Brain Stimulation?

Do you know someone who has been damaged by experimental psychiatric treatments including transcranial magnetic stimulation (TMS), vagus nerve stimulation (VNS), deep brain stimulation (DBS) or any other electric shock or magnetic wave to the brain? Report abuse.

Join our List



Make a one-time or recurring donation of any amount using your checking account.

Make a one-time donation using your credit or debit card.

CCHR Nashville is a qualified 501(c)(3) organization. All contributions are tax deductible to the fullest extent of the law.

Dr. Joseph Sharpe Takes Less Drug Money, Gets Recognized

Dr. Joseph Sharpe

Dr. Joseph Sharpe

NASHVILLE, TN: recently recognized Dr. Joseph McConnico Sharpe of the Nashville Wellness Center as “best in psychiatry” in Nashville.

Dr. Joseph Sharpe graduated from the University of Tennessee, Memphis medical school in 1999 and then went on to Duke University in Durham, North Carolina. Dr. Sharpe currently maintains a private practice while also serving at Baptist Hospital in Nashville and Middle Tennessee Medical Center and TrustPoint Hospital in Murfreesboro, Tennessee..

In 2009, ProPublica reports that Sharpe received almost $41,000 from drug companies, most notably Eli Lilly ($37,900 for speaking) and Pfizer ($3000 for speaking, and $60 for meals).

Figures reported for 2010 are comparable, with Eli Lilly leading ($35939 for speaking, another $2707 for travel) and Pfizer in second ($2000 for speaking, $2732 in travel, $141 meals and $55 for “items, gifts”). He was also given $113 for meals from Cephalon.

2011 brought only $5625 from Eli Lilly for speaking, though Lilly reportedly paid another $1539 for travel and $1036 for meals. AstraZeneca paid only $482 for meals in 2011, and Cephalon $100.

2012 payments included $419 for meals, and 2013 included $240 for meals and another $12 in “expenses” paid by Merck.

It is not clear what criteria was used by to select Dr. Sharpe for recognition.